KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Dividends Paid - Common Dividends Paid - Common Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt repayments

Daily Values

Growth Metrics

LifeMD (LFMD) Asset Writedowns and Impairment (2016 - 2020)

LifeMD filings provide 3 years of Asset Writedowns and Impairment readings, the most recent being $74530.0 for Q4 2020.

On a quarterly basis, Asset Writedowns and Impairment changed N/A to $74530.0 in Q4 2020 year-over-year; TTM through Dec 2021 was $74530.0, a 17.48% increase, with the full-year FY2024 number at $675669.0, up 25.66% from a year prior.
Asset Writedowns and Impairment hit $74530.0 in Q4 2020 for LifeMD, up from -$4576.0 in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $114694.0 in Q4 2016 to a low of -$38027.0 in Q1 2017.
Median Asset Writedowns and Impairment over the past 3 years was -$4576.0 (2017), compared with a mean of $28021.0.